UPDATE: Guggenheim Starts Fate Therapeutics (FATE) at Buy
Tweet Send to a Friend
(Updated - May 31, 2019 7:58 AM EDT)
(updated to add analyst name and comment)Guggenheim analyst Michael Schmidt initiates ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
(updated to add analyst name and comment)Guggenheim analyst Michael Schmidt initiates ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
